Friday, November 22, 2024
HomeTagsPharmaMar

PharmaMar

PharmaMar and Jazz Pharmaceuticals Announce Initiation of Confirmatory Phase 3 Clinical Trial of Zepzelca® (lurbinectedin) for the Treatment of Patients with Relapsed Small Cell...

PharmaMar and partner Jazz Pharmaceuticals plc announced the initiation of a confirmatory Phase 3 clinical trial, LAGOON, evaluating Zepzelca® (lurbinectedin) for the treatment of...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics